Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells

Metallomics

Volumn 6, Issue 4, 2014, Pages 748-773

  Kell, Douglas B ^a   Pretorius, Etheresia ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY;

CELL DAMAGE; CELL STRESS; CELLULAR DAMAGE; DAMAGED CELLS; HYDROXYL RADICAL FORMATION; INFLAMMATORY DISEASE; IRON-STORAGE PROTEIN; SYSTEMS APPROACH;

BODY FLUIDS;

CELL MARKER; COMPLEMENT; FERRITIN; HYDROXYL RADICAL;

CELL DAMAGE; CELL STRESS; CHELATION; CHEMICAL REACTION KINETICS; DEGRADATION; DISEASE MARKER; DISEASE SEVERITY; ERYTHROCYTE STRUCTURE; FERRITIN BLOOD LEVEL; HOMEOSTASIS; HUMAN; INFLAMMATORY DISEASE; IRON STORAGE; LIVER INJURY; OXIDATIVE STRESS; PHENOTYPE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECOGNITION; REVIEW; SYSTEMS BIOLOGY;

ANIMALS; BIOLOGICAL MARKERS; FERRITINS; HUMANS; INFLAMMATION; IRON; LIVER; MODELS, MOLECULAR; OXIDATIVE STRESS; SYSTEMS BIOLOGY;

EID: 84897442035     PISSN: 17565901     EISSN: 1756591X     Source Type: Journal    
DOI: 10.1039/c3mt00347g     Document Type: Review

References (458)

1. A. Mehta A. Deshpande F. Missirlis Genetic screening for novel Drosophila mutants with discrepancies in iron metabolism Biochem. Soc. Trans. 2008 36 1313 1316
2. F. Missirlis S. Kosmidis T. Brody M. Mavrakis S. Holmberg W. F. Odenwald E. M. Skoulakis T. A. Rouault Homeostatic mechanisms for iron storage revealed by genetic manipulations and live imaging of Drosophila ferritin Genetics 2007 177 89 100
3. D. Q. D. Pham J. J. Winzerling Insect ferritins: Typical or atypical? Biochim. Biophys. Acta 2010 1800 824 833
4. X. Tang B. Zhou Ferritin is the key to dietary iron absorption and tissue iron detoxification in Drosophila melanogaster FASEB J. 2013 27 288 298
5. P. Arosio R. Ingrassia P. Cavadini Ferritins: A family of molecules for iron storage, antioxidation and more Biochim. Biophys. Acta 2009 1790 589 599
6. B. S. Skikne C. H. Flowers J. D. Cook Serum transferrin receptor: a quantitative measure of tissue iron deficiency Blood 1990 75 1870 1876
7. Y. Beguin Soluble transferrin receptor for the evaluation of erythropoiesis and iron status Clin. Chim. Acta 2003 329 9 22
8. B. S. Skikne Serum transferrin receptor Am. J. Hematol. 2008 83 872 874
9. B. S. Skikne K. Punnonen P. H. Caldron M. T. Bennett M. Rehu G. H. Gasior J. S. Chamberlin L. A. Sullivan K. R. Bray P. C. Southwick Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: A prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index Am. J. Hematol. 2011 86 923 927
10. E. Klipp, R. Herwig, A. Kowald, C. Wierling and H. Lehrach, Systems biology in practice: concepts, implementation and clinical application, Wiley/VCH, Berlin, 2005
11. D. B. Kell and J. D. Knowles, The role of modeling in systems biology, in System modeling in cellular biology: from concepts to nuts and bolts, ed., Z. Szallasi, J. Stelling, and, V. Periwal, MIT Press, Cambridge, 2006, pp. 3-18
12. D. B. Kell Metabolomics, modelling and machine learning in systems biology: towards an understanding of the languages of cells. The 2005 Theodor Bücher lecture FEBS J. 2006 273 873 894
13. B. Ø. Palsson, Systems biology: properties of reconstructed networks, Cambridge University Press, Cambridge, 2006
14. U. Alon, An introduction to systems biology: design principles of biological circuits, Chapman and Hall/CRC, London, 2006
15. D. B. Kell Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases BMC Med. Genomics 2009 2 2
16. V. Hower P. Mendes F. M. Torti R. Laubenbacher S. Akman V. Shulaev S. V. Torti A general map of iron metabolism and tissue-specific subnetworks Mol. Biosyst. 2009 5 422 443
17. D. B. Kell Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples Arch. Toxicol. 2010 577 825 889
18. C. Funke S. A. Schneider D. Berg D. B. Kell Genetics and iron in the systems biology of Parkinson's disease and some related disorders Neurochem. Int. 2013 62 637 652
19. S. Mitchell and P. Mendes, A Computational Model of Liver Iron Metabolism, http://arxiv.org/pdf/1308.5826v1.pdf, 2013
20. L. C. Jellen J. L. Beard B. C. Jones Systems genetics analysis of iron regulation in the brain Biochimie 2009 91 1255 1259
21. B. C. Jones J. L. Beard J. N. Gibson E. L. Unger R. P. Allen K. A. McCarthy C. J. Earley Systems genetic analysis of peripheral iron parameters in the mouse Am. J. Physiol.: Regul., Integr. Comp. Physiol. 2007 293 R116 R124
22. D. Hwang I. Y. Lee H. Yoo N. Gehlenborg J. H. Cho B. Petritis D. Baxter R. Pitstick R. Young D. Spicer N. D. Price J. G. Hohmann S. J. Dearmond G. A. Carlson L. E. Hood A systems approach to prion disease Mol. Syst. Biol. 2009 5 252
23. L. Yin E. L. Unger L. C. Jellen C. J. Earley R. P. Allen A. Tomaszewicz J. C. Fleet B. C. Jones Systems genetic analysis of multivariate response to iron deficiency in mice Am. J. Physiol.: Regul., Integr. Comp. Physiol. 2012 302 R1282 R1296
24. C. Berzuini P. C. Franzone M. Stefanelli C. Viganotti Iron kinetics: modelling and parameter estimation in normal and anemic states Comput. Biomed. Res. 1978 11 209 227
25. P. C. Franzone A. Paganuzzi M. Stefanelli A mathematical model of iron metabolism J. Math. Biol. 1982 15 173 201
26. T. J. S. Lopes T. Luganskaja M. Vujić Spasić M. W. Hentze M. U. Muckenthaler K. Schümann J. G. Reich Systems analysis of iron metabolism: the network of iron pools and fluxes BMC Syst. Biol. 2010 4 112
27. G. Winkelmann Ecology of siderophores with special reference to the fungi Biometals 2007 20 379 392
28. M. Sandy A. Butler Microbial iron acquisition: marine and terrestrial siderophores Chem. Rev. 2009 109 4580 4595
29. R. C. Hider X. Kong Chemistry and biology of siderophores Nat. Prod. Rep. 2010 27 637 657
30. M. Miethke Molecular strategies of microbial iron assimilation: from high-affinity complexes to cofactor assembly systems Metallomics 2013 5 15 28
31. S. Akatsuka Y. Yamashita H. Ohara Y. T. Liu M. Izumiya K. Abe M. Ochiai L. Jiang H. Nagai Y. Okazaki H. Murakami Y. Sekido E. Arai Y. Kanai O. Hino T. Takahashi H. Nakagama S. Toyokuni Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer PLoS One 2012 7 e43403
32. S. Goldstein D. Meyerstein G. Czapski The Fenton reagents Free Radical Biol. Med. 1993 15 435 445
33. S. Toyokuni Iron and carcinogenesis: from Fenton reaction to target genes Redox Rep. 2002 7 189 197
34. P. Wardman L. P. Candeias Fenton chemistry: An introduction Radiat. Res. 1996 145 523 531
35. C. C. Winterbourn Toxicity of iron and hydrogen peroxide: the Fenton reaction Toxicol. Lett. 1995 82-83 969 974
36. X. Liu E. C. Theil Ferritins: dynamic management of biological iron and oxygen chemistry Acc. Chem. Res. 2005 38 167 175
37. E. C. Theil H. Chen C. Miranda H. Janser B. Elsenhans M. T. Nunez F. Pizarro K. Schumann Absorption of iron from ferritin is independent of heme iron and ferrous salts in women and rat intestinal segments J. Nutr. 2012 142 478 483
38. M. C. Linder Mobilization of stored iron in mammals: a review Nutrients 2013 5 4022 4050
39. K. H. Ebrahimi E. Bill P. L. Hagedoorn W. R. Hagen The catalytic center of ferritin regulates iron storage via Fe(II)-Fe(III) displacement Nat. Chem. Biol. 2012 8 941 948
40. F. S. Porter Erythrocyte ferritin Pediatr. Res. 1973 7 954 957
41. E. R. Bauminger S. G. Cohen S. Ofer E. A. Rachmilewitz Quantitative studies of ferritinlike iron in erythrocytes of thalassemia, sickle-cell anemia, and hemoglobin Hammersmith with Mössbauer spectroscopy Proc. Natl. Acad. Sci. U. S. A. 1979 76 939 943
42. A. Jacobs S. W. Peters E. R. Bauminger J. Eikelboom S. Ofer E. A. Rachmilewitz Ferritin concentration in normal and abnormal erythrocytes measured by immunoradiometric assay with antibodies to heart and spleen ferritin and Mössbauer spectroscopy Br. J. Haematol. 1981 49 201 207
43. M. B. Van der Weyden H. Fong L. Hallam M. J. Breidahl A rapid and simple assay for human erythrocyte ferritin Clin. Chim. Acta 1983 127 397 401
44. M. B. Van Der Weyden H. Fong H. H. Salem R. G. Batey F. J. Dudley Erythrocyte ferritin content in idiopathic haemochromatosis and alcoholic liver disease with iron overload BMJ 1983 286 752 754
45. L. Muylle F. L. Van de Vyver P. P. Blockx Erythrocyte ferritin content in idiopathic haemochromatosis and alcoholic liver disease with iron overload BMJ 1983 286 2064 2065
46. A. Piperno M. T. Taddei M. Sampietro S. Fargion P. Arosio G. Fiorelli Erythrocyte ferritin in thalassemia syndromes Acta Haematol. 1984 71 251 256
47. H. H. Bodemann A. Rieger K. J. Bross H. Schroter-Urban G. W. Lohr Erythrocyte and plasma ferritin in normal subjects, blood donors and iron deficiency anemia patients Blut 1984 48 131 137
48. A. Piperno M. Sampietro M. T. Taddei G. Fiorelli Factors affecting erythrocyte ferritin content in thalassaemia intermedia Br. J. Haematol. 1984 56 173 174
49. S. W. Peters S. J. May A. Jacobs Erythrocyte ferritin concentration in patients with myelodysplastic syndromes J. Clin. Pathol. 1985 38 113 114
50. M. K. Cruickshank J. Ninness A. Curtis R. M. Barr P. R. Flanagan C. N. Ghent L. S. Valberg Usefulness of erythrocyte ferritin analysis in hereditary hemochromatosis CMAJ 1987 136 1259 1264
51. M. I. Oshtrakh V. A. Semionkin Mössbauer study of red blood cells from patients with erythremia FEBS Lett. 1989 257 41 44
52. E. R. Bauminger E. Fibach A. M. Konijn S. Ofer E. A. Rachmilewitz Mössbauer studies of iron uptake, ferritin and hemoglobin synthesis and denaturation in erythroid cell cultures Hyperfine Interact. 1991 66 11 23
53. V. Christopoulou A. Varsou A. Travlou G. Drivas Erythrocyte ferritin in patients with chronic renal failure and heterozygous beta-thalassemia Nephron 2002 91 463 467
54. C. Novembrino A. Porcella D. Conte A. F. de Vecchi G. Buccianti S. Lonati L. Duca A. Ciani F. Bamonti-Catena Erythrocyte ferritin concentration: analytical performance of the immunoenzymatic IMx-Ferritin (Abbott) assay Clin. Chem. Lab. Med. 2005 43 449 453
55. H. Beving L. E. G. Eriksson C. L. Davey D. B. Kell Dielectric properties of human blood and erythrocytes at radio frequencies (0.2-10 MHz): dependence on medium composition Eur. Biophys. J. 1994 23 207 215
56. C. Cai A. Ching C. Lagace T. Linsenmayer Nuclear ferritin-mediated protection of corneal epithelial cells from oxidative damage to DNA Dev. Dyn. 2008 237 2676 2683
57. N. Surguladze K. M. Thompson J. L. Beard J. R. Connor M. G. Fried Interactions and reactions of ferritin with DNA J. Biol. Chem. 2004 279 14694 14702
58. N. Surguladze S. Patton A. Cozzi M. G. Fried J. R. Connor Characterization of nuclear ferritin and mechanism of translocation Biochem. J. 2005 388 731 740
59. M. V. Nurminskaya C. J. Talbot D. I. Nurminsky K. E. Beazley T. F. Linsenmayer Nuclear ferritin: a ferritoid-ferritin complex in corneal epithelial cells Invest. Ophthalmol. Visual Sci. 2009 50 3655 3661
60. H. L. Storr B. Kind D. A. Parfitt J. P. Chapple M. Lorenz K. Koehler A. Huebner A. J. Clark Deficiency of ferritin heavy-chain nuclear import in triple A syndrome implies nuclear oxidative damage as the primary disease mechanism Mol. Endocrinol. 2009 23 2086 2094
61. A. A. Alkhateeb J. R. Connor Nuclear ferritin: A new role for ferritin in cell biology Biochim. Biophys. Acta 2010 1800 793 797
62. P. Arosio S. Levi Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage Biochim. Biophys. Acta 2010 1800 783 792
63. A. Campanella E. Rovelli P. Santambrogio A. Cozzi F. Taroni S. Levi Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia Hum. Mol. Genet. 2009 18 1 11
64. W. S. Wu Y. S. Zhao Z. H. Shi S. Y. Chang G. J. Nie X. L. Duan S. M. Zhao Q. Wu Z. L. Yang B. L. Zhao Y. Z. Chang Mitochondrial ferritin attenuates beta-amyloid-induced neurotoxicity: reduction in oxidative damage through the Erk/P38 mitogen-activated protein kinase pathways Antioxid. Redox Signaling 2013 18 158 169
65. S. C. Andrews The Ferritin-like superfamily: Evolution of the biological iron storeman from a rubrerythrin-like ancestor Biochim. Biophys. Acta 2010 1800 691 705
66. K. Orino K. Watanabe Molecular, physiological and clinical aspects of the iron storage protein ferritin Vet. J. 2008 178 191 201
67. M. A. Knovich J. A. Storey L. G. Coffman S. V. Torti F. M. Torti Ferritin for the clinician Blood Rev. 2009 23 95 104
68. W. Wang M. A. Knovich L. G. Coffman F. M. Torti S. V. Torti Serum ferritin: Past, present and future Biochim. Biophys. Acta 2010 1800 760 769
69. R. K. Watt The many faces of the octahedral ferritin protein Biometals 2011 24 489 500
70. E. C. Theil Ferritin: The Protein Nanocage and Iron Biomineral in Health and in Disease Inorg. Chem. 2013 52 12223 12233
71. P. M. Harrison P. Arosio Ferritins: Molecular properties, iron storage function and cellular regulation Biochim. Biophys. Acta 1996 1275 161 203
72. P. Rucker F. M. Torti S. V. Torti Role of H and L subunits in mouse ferritin J. Biol. Chem. 1996 271 33352 33357
73. E. C. Theil Ferritin protein nanocages use ion channels, catalytic sites, and nucleation channels to manage iron/oxygen chemistry Curr. Opin. Chem. Biol. 2011 15 304 311
74. R. R. Crichton J. P. Declercq X-ray structures of ferritins and related proteins Biochim. Biophys. Acta 2010 1800 706 718
75. D. J. E. Huard K. M. Kane F. A. Tezcan Re-engineering protein interfaces yields copper-inducible ferritin cage assembly Nat. Chem. Biol. 2013 9 169 176
76. F. Bou-Abdallah G. Zhao G. Biasiotto M. Poli P. Arosio N. D. Chasteen Facilitated diffusion of iron(II) and dioxygen substrates into human H-chain ferritin. A fluorescence and absorbance study employing the ferroxidase center substitution Y34W J. Am. Chem. Soc. 2008 130 17801 17811
77. F. Bou-Abdallah The iron redox and hydrolysis chemistry of the ferritins Biochim. Biophys. Acta 2010 1800 719 731
78. T. Tosha H. L. Ng O. Bhattasali T. Alber E. C. Theil Moving Metal Ions through Ferritin-Protein Nanocages from Three-Fold Pores to Catalytic Sites J. Am. Chem. Soc. 2010 132 14562 14569
79. P. Turano D. Lalli I. C. Felli E. C. Theil I. Bertini NMR reveals pathway for ferric mineral precursors to the central cavity of ferritin Proc. Natl. Acad. Sci. U. S. A. 2010 107 545 550
80. I. Bertini D. Lalli S. Mangani C. Pozzi C. Rosa E. C. Theil P. Turano Structural Insights into the Ferroxidase Site of Ferritins from Higher Eukaryotes J. Am. Chem. Soc. 2012 134 6169 6176
81. F. Carmona Ò. Palacios N. Gálvez R. Cuesta S. Atrian M. Capdevila J. M. Domínguez-Vera Ferritin iron uptake and release in the presence of metals and metalloproteins: Chemical implications in the brain Coord. Chem. Rev. 2013 257 2752 2764
82. E. C. Theil R. K. Behera T. Tosha Ferritins for Chemistry and for Life Coord. Chem. Rev. 2013 257 579 586
83. T. Tosha R. K. Behera E. C. Theil Ferritin ion channel disorder inhibits Fe(II)/O2 reactivity at distant sites Inorg. Chem. 2012 51 11406 11411
84. R. K. Watt A unified model for ferritin iron loading by the catalytic center: implications for controlling free iron during oxidative stress ChemBioChem 2013 14 415 419
85. R. K. Watt R. J. Hilton D. M. Graff Oxido-reduction is not the only mechanism allowing ions to traverse the ferritin protein shell Biochim. Biophys. Acta 2010 1800 745 759
86. M. R. Hasan T. Tosha E. C. Theil Ferritin Contains Less Iron (Fe-59) in Cells When the Protein Pores Are Unfolded by Mutation J. Biol. Chem. 2008 283 31394 31400
87. J. M. Domínguez-Vera B. Fernández N. Gálvez Native and synthetic ferritins for nanobiomedical applications: recent advances and new perspectives Future Med. Chem. 2010 2 609 618
88. G. Melman F. Bou-Abdallah E. Vane P. Maura P. Arosio A. Melman Iron release from ferritin by flavin nucleotides Biochim. Biophys. Acta 2013 1830 4669 4674
89. F. Bou-Abdallah J. McNally X. X. Liu A. Melman Oxygen catalyzed mobilization of iron from ferritin by iron(III) chelate ligands Chem. Commun. 2011 47 731 733
90. F. M. Torti S. V. Torti Regulation of ferritin genes and protein Blood 2002 99 3505 3516
91. H. Yamanishi S. Iyama Y. Yamaguchi Y. Kanakura Y. Iwatani Relation between iron content of serum ferritin and clinical status factors extracted by factor analysis in patients with hyperferritinemia Clin. Biochem. 2002 35 523 529
92. T. Konz E. Añón Alvarez M. Montes-Bayon A. Sanz-Medel Antibody labeling and elemental mass spectrometry (inductively coupled plasma-mass spectrometry) using isotope dilution for highly sensitive ferritin determination and iron-ferritin ratio measurements Anal. Chem. 2013 85 8334 8340
93. Y. H. Pan K. Sader J. J. Powell A. Bleloch M. Gass J. Trinick A. Warley A. Li R. Brydson A. Brown 3D morphology of the human hepatic ferritin mineral core: new evidence for a subunit structure revealed by single particle analysis of HAADF-STEM images J. Struct. Biol. 2009 166 22 31
94. J. Dobson Magnetic iron compounds in neurological disorders Ann. N. Y. Acad. Sci. 2004 1012 183 192
95. J. Gała̧zka-Friedman Iron as a risk factor in neurological diseases Hyperfine Interact. 2008 182 31 44
96. D. G. Meyers The iron hypothesis-does iron cause atherosclerosis? Clin. Cardiol. 1996 19 925 929
97. P. Arosio M. Yokota J. W. Drysdale Characterization of Serum Ferritin in Iron Overload-Possible Identity to Natural Apoferritin Br. J. Haematol. 1977 36 199 207
98. M. Rudeck T. Volk N. Sitte T. Grune Ferritin oxidation in vitro: implication of iron release and degradation by the 20S proteasome IUBMB Life 2000 49 451 456
99. T. Z. Kidane E. Sauble M. C. Linder Release of iron from ferritin requires lysosomal activity Am. J. Physiol. 2006 291 C445 C455
100. Y. Zhang M. Mikhael D. Xu Y. Li S. Soe-Lin B. Ning W. Li G. Nie Y. Zhao P. Ponka Lysosomal proteolysis is the primary degradation pathway for cytosolic ferritin and cytosolic ferritin degradation is necessary for iron exit Antioxid. Redox Signaling 2010 13 999 1009
101. T. Asano M. Komatsu Y. Yamaguchi-Iwai F. Ishikawa N. Mizushima K. Iwai Distinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells Mol. Cell. Biol. 2011 31 2040 2052
102. T. C. Iancu Ultrastructural aspects of iron storage, transport and metabolism J. Neural Transm. 2011 118 329 335
103. A. Terman T. Kurz Lysosomal Iron, Iron Chelation, and Cell Death Antioxid. Redox Signaling 2013 18 888 898
104. R. Vidal L. Miravalle X. Gao A. G. Barbeito M. A. Baraibar S. K. Hekmatyar M. Widel N. Bansal M. B. Delisle B. Ghetti Expression of a mutant form of the ferritin light chain gene induces neurodegeneration and iron overload in transgenic mice J. Neurosci. 2008 28 60 67
105. E. Miyazaki J. Kato M. Kobune K. Okumura K. Sasaki N. Shintani P. Arosio Y. Niitsu Denatured H-ferritin subunit is a major constituent of haemosiderin in the liver of patients with iron overload Gut 2002 50 413 419
106. P. Zamboni M. Izzo L. Fogato S. Carandina V. Lanzara Urine hemosiderin: a novel marker to assess the severity of chronic venous disease J. Vasc. Surg. 2003 37 132 136
107. C. Quintana S. Bellefqih J. Y. Laval J. L. Guerquin-Kern T. D. Wu J. Avila I. Ferrer R. Arranz C. Patino Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level J. Struct. Biol. 2006 153 42 54
108. C. Quintana About the presence of hemosiderin in the hippocampus of Alzheimer patients J. Alzheimer's Dis. 2007 12 157 160
109. P. Zamboni S. Lanzara F. Mascoli A. Caggiati A. Liboni Inflammation in venous disease Int. Angiol. 2008 27 361 369
110. F. Maldonado J. G. Parambil E. S. Yi P. A. Decker J. H. Ryu Haemosiderin-laden macrophages in the bronchoalveolar lavage fluid of patients with diffuse alveolar damage Eur. Respir. J. 2009 33 1361 1366
111. H. L. Persson L. K. Vainikka Lysosomal iron in pulmonary alveolar proteinosis: a case report Eur. Respir. J. 2009 33 673 679
112. N. Sakalihasan J. B. Michel Functional imaging of atherosclerosis to advance vascular biology Eur. J. Vasc. Endovasc. Surg. 2009 37 728 734
113. A. Terman U. T. Brunk Lipofuscin Int. J. Biochem. Cell Biol. 2004 36 1400 1404
114. T. Jung N. Bader T. Grune Lipofuscin: formation, distribution, and metabolic consequences Ann. N. Y. Acad. Sci. 2007 1119 97 111
115. K. L. Double V. N. Dedov H. Fedorow E. Kettle G. M. Halliday B. Garner U. T. Brunk The comparative biology of neuromelanin and lipofuscin in the human brain Cell. Mol. Life Sci. 2008 65 1669 1682
116. A. Höhn T. Jung S. Grimm T. Grune Lipofuscin-bound iron is a major intracellular source of oxidants: role in senescent cells Free Radical Biol. Med. 2010 48 1100 1108
117. M. Gerlach A. X. Trautwein L. Zecca M. B. H. Youdim P. Riederer Mössbauer Spectroscopic Studies of Purified Human Neuromelanin Isolated from the Substantia-Nigra J. Neurochem. 1995 65 923 926
118. K. L. Double M. Gerlach V. Schunemann A. X. Trautwein L. Zecca M. Gallorini M. B. Youdim P. Riederer D. Ben-Shachar Iron-binding characteristics of neuromelanin of the human substantia nigra Biochem. Pharmacol. 2003 66 489 494
119. M. Gerlach K. L. Double D. Ben-Shachar L. Zecca M. B. Youdim P. Riederer Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease Neurotoxic Res. 2003 5 35 44
120. L. Zecca M. Gallorini V. Schunemann A. X. Trautwein M. Gerlach P. Riederer P. Vezzoni D. Tampellini Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes J. Neurochem. 2001 76 1766 1773
121. S. Bohic K. Murphy W. Paulus P. Cloetens M. Salome J. Susini K. Double Intracellular Chemical Imaging of the Developmental Phases of Human Neuromelanin Using Synchrotron X-ray Microspectroscopy Anal. Chem. 2008 80 9557 9566
122. F. Tribl E. Asan T. Arzberger T. Tatschner E. Langenfeld H. E. Meyer G. Bringmann P. Riederer M. Gerlach K. Marcus Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach Mol. Cell. Proteomics 2009 8 1832 1838
123. H. Saito A. Tomita H. Ohashi H. Maeda H. Hayashi T. Naoe Determination of ferritin and hemosiderin iron in patients with normal iron stores and iron overload by serum ferritin kinetics Nagoya J. Med. Sci. 2012 74 39 49
124. H. Saito H. Hayashi A. Tomita H. Ohashi H. Maeda T. Naoe Increasing and Decreasing Phases of Ferritin and Hemosiderin Iron Determined by Serum Ferritin Kinetics Nagoya J. Med. Sci. 2013 75 213 223
125. G. Ricolleau C. Charbonnel L. Lode D. Loussouarn M. P. Joalland R. Bogumil S. Jourdain S. Minvielle M. Campone R. Déporte-Fety L. Campion P. Jézéquel Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors Proteomics 2006 6 1963 1975
126. M. E. del Castillo Busto M. Montes-Bayón A. Sanz-Medel The potential of mass spectrometry to study iron-containing proteins used in clinical diagnosis Anal. Chim. Acta 2009 634 1 14
127. M. Hoppler C. Zeder T. Walczyk Quantification of Ferritin-Bound Iron in Plant Samples by Isotope Tagging and Species-Specific Isotope Dilution Mass Spectrometry Anal. Chem. 2009 81 7368 7372
128. H. Q. Huang X. H. Hu X. P. Fang T. M. Cao B. Kong Characteristics of H and L Subunits with Mass Spectrometry, Electrophoresis and Transmission Electron Microscopy in Liver Ferritin of Dasyatis Akajei Chin. J. Anal. Chem. 2009 37 631 636
129. P. Nielsen U. Günther M. Dürken R. Fischer J. Düllmann Serum ferritin iron in iron overload and liver damage: Correlation to body iron stores and diagnostic relevance J. Lab. Clin. Med. 2000 135 413 418
130. K. Watanabe Y. Yamashita K. Ohgawara M. Sekiguchi N. Satake K. Orino S. Yamamoto Iron content of rat serum ferritin J. Vet. Med. Sci. 2001 63 587 589
131. N. Bresgen H. Jaksch H. Lacher I. Ohlenschlager K. Uchida P. M. Eckl Iron-mediated oxidative stress plays an essential role in ferritin-induced cell death Free Radical Biol. Med. 2010 48 1347 1357
132. A. A. Alkhateeb B. Han J. R. Connor Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages Breast Cancer Res. Treat. 2013 137 733 744
133. T. Kurz B. Gustafsson U. T. Brunk Cell sensitivity to oxidative stress is influenced by ferritin autophagy Free Radical Biol. Med. 2011 50 1647 1658
134. B. Garner K. Roberg U. T. Brunk Endogenous ferritin protects cells with iron-laden lysosomes against oxidative stress Free Radical Res. 1998 29 103 114
135. B. Garner W. Li K. Roberg U. T. Brunk On the cytoprotective role of ferritin in macrophages and its ability to enhance lysosomal stability Free Radical Res. 1997 27 487 500
136. H. L. Persson K. J. Nilsson U. T. Brunk Novel cellular defenses against iron and oxidation: ferritin and autophagocytosis preserve lysosomal stability in airway epithelium Redox Rep. 2001 6 57 63
137. T. Kurz J. W. Eaton U. T. Brunk The role of lysosomes in iron metabolism and recycling Int. J. Biochem. Cell Biol. 2011 43 1686 1697
138. C. Ferreira D. Bucchini M. E. Martin S. Levi P. Arosio B. Grandchamp C. Beaumont Early embryonic lethality of H ferritin gene deletion in mice J. Biol. Chem. 2000 275 3021 3024
139. C. Ferreira P. Santambrogio M. E. Martin V. Andrieu G. Feldmann D. Henin C. Beaumont H ferritin knockout mice: a model of hyperferritinemia in the absence of iron overload Blood 2001 98 525 532
140. J. t. Wilkinson X. Di K. Schönig J. L. Buss N. D. Kock J. M. Cline T. L. Saunders H. Bujard S. V. Torti F. M. Torti Tissue-specific expression of ferritin H regulates cellular iron homoeostasis in vivo Biochem. J. 2006 395 501 507
141. G. Hetet I. Devaux N. Soufir B. Grandchamp C. Beaumont Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (SLC11A3) mutations Blood 2003 102 1904 1910
142. K. P. Burdon S. Sharma C. S. Chen D. P. Dimasi D. A. Mackey J. E. Craig A novel deletion in the FTL gene causes hereditary hyperferritinemia cataract syndrome (HHCS) by alteration of the transcription start site Hum. Mutat. 2007 28 742
143. C. Kannengiesser A. M. Jouanolle G. Hetet A. Mosser F. Muzeau D. Henry E. Bardou-Jacquet M. Mornet P. Brissot Y. Deugnier B. Grandchamp C. Beaumont A new missense mutation in the L ferritin coding sequence associated with elevated levels of glycosylated ferritin in serum and absence of iron overload Haematologica 2009 94 335 339
144. J. Álvarez-Coca-Gonzalez M. I. Moreno-Carralero J. Martinez-Pérez M. Méndez M. García-Ros M. J. Morán-Jiménez The hereditary hyperferritinemia-cataract syndrome: a family study Eur. J. Pediatr. 2010 169 1553 1555
145. C. Beaumont, Miscellaneous Iron-Related Disorders, in Iron Physiology and Pathophysiology in Humans, ed., G. J. Anderson, and, G. D. McLaren, 2012, pp. 417-439
146. S. Luscieti G. Tolle J. Aranda C. B. Campos F. Risse É. Morán M. U. Muckenthaler M. Sánchez Novel mutations in the ferritin-L iron-responsive element that only mildly impair IRP binding cause hereditary hyperferritinaemia cataract syndrome Orphanet. J. Rare Dis. 2013 8 30
147. G. A. Agasthya B. C. Harrawood J. P. Shah A. J. Kapadia Sensitivity analysis for liver iron measurement through neutron stimulated emission computed tomography: a Monte Carlo study in GEANT4 Phys. Med. Biol. 2012 57 113 126
148. P. Nielsen R. Engelhardt J. Dullmann R. Fischer Non-invasive liver iron quantification by SQUID-biosusceptometry and serum ferritin iron as new diagnostic parameters in hereditary hemochromatosis Blood Cells, Mol., Dis. 2002 29 451 458
149. A. Castiella J. M. Alústiza J. I. Emparanza E. M. Zapata B. Costero M. I. Díez Liver iron concentration quantification by MRI: are recommended protocols accurate enough for clinical practice? Eur. Radiol. 2010 21 137 141
150. M. I. Argyropoulou L. Astrakas MRI evaluation of tissue iron burden in patients with beta-thalassaemia major Pediatr. Radiol. 2007 37 1191 1200
151. O. Dereure N. Jumez D. Bessis B. Gallix B. Guillot Measurement of liver iron content by magnetic resonance imaging in 20 patients with overt porphyria cutanea tarda before phlebotomy therapy: a prospective study Acta Derm.-Venereol. 2008 88 341 345
152. K. M. Musallam M. D. Cappellini J. C. Wood I. Motta G. Graziadei H. Tamim A. T. Taher Elevated liver iron concentration is a marker of increased morbidity in patients with beta thalassemia intermedia Haematologica 2011 96 1605 1612
153. K. M. Musallam M. D. Cappellini A. T. Taher Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with beta-thalassemia intermedia Blood Cells, Mol., Dis. 2013 51 35 38
154. V. Positano B. Salani A. Pepe M. F. Santarelli D. De Marchi A. Ramazzotti B. Favilli E. Cracolici M. Midiri P. Cianciulli M. Lombardi L. Landini Improved T2* assessment in liver iron overload by magnetic resonance imaging Magn. Reson. Imaging 2009 27 188 197
155. C. Rose P. Vandevenne E. Bourgeois N. Cambier O. Ernst Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients Eur. J. Haematol. 2006 77 145 149
156. K. Tziomalos V. Perifanis Liver iron content determination by magnetic resonance imaging World J. Gastroenterol. 2010 16 1587 1597
157. S. Tony S. Daar M. Elshinawy S. Al-Zadjaly M. Al-Khabori Y. Wali T2* MRI in regularly transfused children with thalassemia intermedia: serum ferritin does not reflect liver iron stores Pediatr. Hematol. Oncol. 2012 29 579 584
158. K. Ziv G. Meir A. Harmelin E. Shimoni E. Klein M. Neeman Ferritin as a reporter gene for MRI: chronic liver over expression of H-ferritin during dietary iron supplementation and aging NMR Biomed. 2010 23 523 531
159. E. M. Haacke N. Y. Cheng M. J. House Q. Liu J. Neelavalli R. J. Ogg A. Khan M. Ayaz W. Kirsch A. Obenaus Imaging iron stores in the brain using magnetic resonance imaging Magn. Reson. Imaging 2005 23 1 25
160. W. Kirsch G. McAuley B. Holshouser F. Petersen M. Ayaz H. V. Vinters C. Dickson E. M. Haacke W. Britt III J. Larsen I. Kim C. Mueller M. Schrag D. Kido Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia J. Alzheimer's Dis. 2009 17 599 609
161. W. Zheng H. Nichol S. Liu Y. C. Cheng E. M. Haacke Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging NeuroImage 2013 78C 68 74
162. M. J. Kim D. G. Mitchell K. Ito H. W. Hann Y. N. Park P. N. Kim Hepatic iron deposition on MR imaging in patients with chronic liver disease: correlation with serial serum ferritin concentration Abdom. Imaging 2001 26 149 156
163. A. W. Olthof P. E. Sijens H. G. Kreeftenberg P. Kappert R. Irwan E. J. van der Jagt M. Oudkerk Correlation between serum ferritin levels and liver iron concentration determined by MR imaging: impact of hematologic disease and inflammation Magn. Reson. Imaging 2007 25 228 231
164. O. G. Papakonstantinou T. G. Maris V. Kostaridou A. D. Gouliamos G. K. Koutoulas A. E. Kalovidouris G. B. Papavassiliou G. Kordas C. Kattamis L. J. Vlahos et al., Assessment of liver iron overload by T2-quantitative magnetic resonance imaging: correlation of T2-QMRI measurements with serum ferritin concentration and histologic grading of siderosis Magn. Reson. Imaging 1995 13 967 977
165. P. D. Jensen F. T. Jensen T. Christensen J. Ellegaard Evaluation of transfusional iron overload before and during iron chelation by magnetic resonance imaging of the liver and determination of serum ferritin in adult non-thalassaemic patients Br. J. Haematol. 1995 89 880 889
166. P. D. Jensen F. T. Jensen T. Christensen H. Eiskjaer U. Baandrup J. L. Nielsen Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool Blood 2003 101 4632 4639
167. P. D. Jensen F. T. Jensen T. Christensen J. L. Nielsen J. Ellegaard Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients with acquired anemias Blood 2003 101 91 96
168. Z. Pakbaz R. Fischer E. Fung P. Nielsen P. Harmatz E. Vichinsky Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients Pediatr. Blood Cancer 2007 49 329 332
169. A. Taher F. El Rassi H. Isma'eel S. Koussa A. Inati M. D. Cappellini Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia Haematologica 2008 93 1584 1586
170. A. Kolnagou K. Natsiopoulos M. Kleanthous A. Ioannou G. J. Kontoghiorghes Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2* Toxicol. Mech. Methods 2013 23 48 56
171. D. A. Tsitsikas R. Nzouakou V. Ameen B. Sirigireddy R. J. Amos Comparison of Serial Serum Ferritin Measurements and Liver Iron Concentration Assessed by MRI in Adult Transfused Patients with Sickle Cell Disease Eur. J. Haematol. 2014 92 164 167
172. B. J. Ferguson B. S. Skikne K. M. Simpson R. D. Baynes J. D. Cook Serum Transferrin Receptor Distinguishes the Anemia of Chronic Disease from Iron-Deficiency Anemia J. Lab. Clin. Med. 1992 119 385 390
173. K. Punnonen K. Irjala A. Rajamäki Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency Blood 1997 89 1052 1057
174. J. D. Cook Diagnosis and management of iron-deficiency anaemia Best Pract. Res., Clin. Haematol. 2005 18 319 332
175. E. Hanif M. Ayyub M. Anwar W. Ali M. Bashir Evaluation of serum transferrin receptor concentration in diagnosing and differentiating iron deficiency anaemia from anaemia of chronic disorders J. Pak. Med. Assoc. 2005 55 13 16
176. E. Joosten R. Van Loon J. Billen N. Blanckaert R. Fabri W. Pelemans Serum transferrin receptor in the evaluation of the iron status in elderly hospitalized patients with anemia Am. J. Hematol. 2002 69 1 6
177. A. Skoumalová J. Hort Blood markers of oxidative stress in Alzheimer's disease J. Cell. Mol. Med. 2012 16 2291 2300
178. K. Henriksen S. E. O'Bryant H. Hampel J. Q. Trojanowski T. J. Montine A. Jeromin K. Blennow A. Lönneborg T. Wyss-Coray H. Soares C. Bazenet M. Sjögren W. Hu S. Lovestone M. A. Karsdal M. W. Weiner The future of blood-based biomarkers for Alzheimer's disease Alzheimer's Dementia 2014 10 115 131
179. M. Schrag C. Mueller M. Zabel A. Crofton W. M. Kirsch O. Ghribi R. Squitti G. Perry Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis Neurobiol. Dis. 2013 59 100 110
180. K. Ikeda Y. Nakamura T. Kiyozuka J. Aoyagi T. Hirayama R. Nagata H. Ito K. Iwamoto K. Murata Y. Yoshii K. Kawabe Y. Iwasaki Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression Neurodegener. Dis. 2011 8 252 258
181. K. G. Connelly M. Moss P. E. Parsons E. E. Moore F. A. Moore P. C. Giclas P. A. Seligman J. E. Repine Serum ferritin as a predictor of the acute respiratory distress syndrome Am. J. Respir. Crit. Care Med. 1997 155 21 25
182. R. A. Sharkey S. C. Donnelly K. G. Connelly C. E. Robertson C. Haslett J. E. Repine Initial serum ferritin levels in patients with multiple trauma and the subsequent development of acute respiratory distress syndrome Am. J. Respir. Crit. Care Med. 1999 159 1506 1509
183. A. L. Lagan G. J. Quinlan S. Mumby D. D. Melley P. Goldstraw G. J. Bellingan M. R. Hill D. Briggs P. Pantelidis R. M. du Bois K. I. Welsh T. W. Evans Variation in iron homeostasis genes between patients with ARDS and healthy control subjects Chest 2008 133 1302 1311
184. Y. Y. Park Ischemia/reperfusion Lung Injury Increases Serum Ferritin and Heme Oxygenase-1 in Rats Korean J. Physiol. Pharmacol. 2009 13 181 187
185. E. F. Goodall M. S. Haque K. E. Morrison Increased serum ferritin levels in amyotrophic lateral sclerosis (ALS) patients J. Neurol. 2008 255 1652 1656
186. M. Qureshi R. H. Brown Jr. J. T. Rogers M. E. Cudkowicz Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis Open Neurol. J. 2008 2 51 54
187. K. Ikeda T. Hirayama T. Takazawa K. Kawabe Y. Iwasaki Relationships between Disease Progression and Serum Levels of Lipid, Urate, Creatinine and Ferritin in Japanese Patients with Amyotrophic Lateral Sclerosis: A Cross-Sectional Study Intern. Med. 2012 51 1501 1508
188. Y. Nadjar P. Gordon P. Corcia G. Bensimon L. Pieroni V. Meininger F. Salachas Elevated serum ferritin is associated with reduced survival in amyotrophic lateral sclerosis PLoS One 2012 7 e45034
189. X. W. Su Z. Simmons R. M. Mitchell L. Kong H. E. Stephens J. R. Connor Biomarker-Based Predictive Models for Prognosis in Amyotrophic Lateral Sclerosis JAMA Neurol. 2013 70 1505 1511
190. S. Kiechl J. Willeit G. Egger W. Poewe F. Oberhollenzer Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study Circulation 1997 96 3300 3307
191. S. A. You S. R. Archacki G. Angheloiu C. S. Moravec S. Rao M. Kinter E. J. Topol Q. Wang Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis Physiol. Genomics 2003 13 25 30
192. B. Wolff H. Volzke J. Ludemann D. Robinson D. Vogelgesang A. Staudt C. Kessler J. B. Dahm U. John S. B. Felix Association between high serum ferritin levels and carotid atherosclerosis in the study of health in Pomerania (SHIP) Stroke 2004 35 453 457
193. K. A. Reis G. Guz H. Ozdemir Y. Erten V. Atalay Z. Bicik Z. N. Ozkurt M. Bali S. Sindel Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease Int. Heart J. 2005 46 255 264
194. S. A. You Q. Wang Ferritin in atherosclerosis Clin. Chim. Acta 2005 357 1 16
195. J. J. M. Marx A. E. R. Kartikasari N. A. Georgiou Can iron chelators influence the progression of atherosclerosis? Hemoglobin 2008 32 123 134
196. J. L. Sullivan Iron in arterial plaque: A modifiable risk factor for atherosclerosis Biochim. Biophys. Acta 2009 1790 718 723
197. N. Ahluwalia A. Genoux J. Ferrieres B. Perret M. Carayol L. Drouet J. B. Ruidavets Iron status is associated with carotid atherosclerotic plaques in middle-aged adults J. Nutr. 2010 140 812 816
198. R. G. DePalma V. W. Hayes B. K. Chow G. Shamayeva P. E. May L. R. Zacharski Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: A substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial J. Vasc. Surg. 2010 51 1498 1503
199. P. Syrovatka P. Kraml K. Hulikova L. Fialova M. Vejrazka J. Crkovska J. Potockova M. Andel Iron stores are associated with asymptomatic atherosclerosis in healthy men of primary prevention Eur. J. Clin. Invest. 2011 41 846 853
200. L. R. Zacharski R. G. Depalma G. Shamayeva B. K. Chow The Statin-Iron Nexus: Anti-Inflammatory Intervention for Arterial Disease Prevention Am. J. Public Health 2013 103 e105 e112
201. J. T. Hazard J. W. Drysdale Ferritinaemia in cancer Nature 1977 265 755 756
202. B. M. Jones M. Worwood A. Jacobs Serum ferritin in patients with cancer: determination with antibodies to HeLa cell and spleen ferritin Clin. Chim. Acta 1980 106 203 214
203. A. Jacobs Serum ferritin and malignant tumours Med. Oncol. Tumor Pharmacother. 1984 1 149 156
204. J. H. Silber A. E. Evans M. Fridman Models to Predict Outcome from Childhood Neuroblastoma-the Role of Serum Ferritin and Tumor Histology Cancer Res. 1991 51 1426 1433
205. R. L. Nelson F. G. Davis E. Sutter L. H. Sobin J. W. Kikendall P. Bowen Body iron stores and risk of colonic neoplasia J. Natl. Cancer Inst. 1994 86 455 460
206. Z. Kirkali M. Güzelsoy M. U. Mungan G. Kirkali K. Yörükoǧlu Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor size and volume Urol. Int. 1999 62 21 25
207. S. Hercberg C. Estaquio S. Czernichow L. Mennen N. Noisette S. Bertrais J. C. Renversez S. Briancon A. Favier P. Galan Iron status and risk of cancers in the SU.VI.MAX cohort J. Nutr. 2005 135 2664 2668
208. L. R. Zacharski B. K. Chow P. S. Howes G. Shamayeva J. A. Baron R. L. Dalman D. J. Malenka C. K. Ozaki P. W. Lavori Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial J. Natl. Cancer Inst. 2008 100 996 1002
209. K. H. Zhang H. Y. Tian X. Gao W. W. Lei Y. Hu D. M. Wang X. C. Pan M. L. Yu G. J. Xu F. K. Zhao J. G. Song Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition Cancer Res. 2009 69 5340 5348
210. A. A. Alkhateeb K. Leitzel S. M. Ali C. Campbell-Baird M. Evans E. M. Fuchs W. J. Köstler A. Lipton J. Connor Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy PLoS One 2012 7 e51379
211. A. A. Alkhateeb J. R. Connor The significance of ferritin in cancer: Anti-oxidation, inflammation and tumorigenesis Biochim. Biophys. Acta 2013 1836 245 254
212. A. Amid N. Barrowman A. Vijenthira P. Lesser K. Mandel R. Ramphal Risk factors for hyperferritinemia secondary to red blood cell transfusions in pediatric cancer patients Pediatr. Blood Cancer 2013 60 1671 1675
213. A. Alkhateeb L. Zubritsky B. Kinsman K. Leitzel C. Campbell-Baird S. M. Ali J. Connor A. Lipton Elevation in Multiple Serum Inflammatory Biomarkers Predicts Survival of Pancreatic Cancer Patients with Inoperable Disease J. Gastrointest. Cancer 2014 10.1007/12029-013-9564-9
214. R. Orlandi M. De Bortoli C. M. Ciniselli E. Vaghi D. Caccia V. Garrisi S. Pizzamiglio S. Veneroni C. Bonini R. Agresti M. G. Daidone D. Morelli C. Camaschella P. Verderio I. Bongarzone Hepcidin and ferritin blood level as noninvasive tools for predicting breast cancer Ann. Oncol. 2014 10.1093/annonc/mdt490
215. K. Jurczyk M. Wawrzynowicz-Syczewska A. Boroń-Kaczmarska Z. Sych Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis Med. Sci. Monit. 2001 7 962 965
216. D. H. G. Crawford T. L. Murphy L. E. Ramm L. M. Fletcher A. D. Clouston G. J. Anderson V. N. Subramaniam L. W. Powell G. A. Ramm Serum Hyaluronic Acid with Serum Ferritin Accurately Predicts Cirrhosis and Reduces the Need for Liver Biopsy in C282Y Hemochromatosis Hepatology 2009 49 418 425
217. T. C. H. Tan D. H. Crawford M. E. Franklin L. A. Jaskowski G. A. Macdonald J. R. Jonsson M. J. Watson P. J. Taylor L. M. Fletcher The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis Liver Int. 2012 32 1391 1399
218. M. E. Olesnevich M. Fanelli Kuczmarski M. Mason C. Fang A. B. Zonderman M. K. Evans Serum ferritin levels associated with increased risk for developing CHD in a low-income urban population Public Health Nutr. 2012 15 1291 1298
219. K. C. Sung S. M. Kang E. J. Cho J. B. Park S. H. Wild C. D. Byrne Ferritin is independently associated with the presence of coronary artery calcium in 12,033 men Arterioscler., Thromb., Vasc. Biol. 2012 32 2525 2530
220. Y. Zhou T. Liu C. Tian P. Kang C. Jia Association of serum ferritin with coronary artery disease Clin. Biochem. 2012 45 1336 1341
221. B. Ponikowska T. Suchocki B. Paleczny M. Olesinska S. Powierza L. Borodulin-Nadzieja K. Reczuch S. von Haehling W. Doehner S. D. Anker J. G. Cleland E. A. Jankowska Iron Status and Survival in Diabetic Patients With Coronary Artery Disease Diabetes Care 2013 36 4147 4156
222. J. T. Salonen T. P. Tuomainen K. Nyyssonen H. M. Lakka K. Punnonen Relation between iron stores and non-insulin dependent diabetes in men: case-control study BMJ 1998 317 727
223. E. S. Ford M. E. Cogswell Diabetes and serum ferritin concentration among U.S. adults Diabetes Care 1999 22 1978 1983
224. J. G. Wilson J. H. Lindquist S. C. Grambow E. D. Crook J. F. Maher Potential role of increased iron stores in diabetes Am. J. Med. Sci. 2003 325 332 339
225. R. Jiang J. E. Manson J. B. Meigs J. Ma N. Rifai F. B. Hu Body iron stores in relation to risk of type 2 diabetes in apparently healthy women JAMA 2004 291 711 717
226. M. Mert M. Korkmaz M. Temizel M. Acar The Level of Ferritin in Diabetic and Nondiabetic Patients with Acute Myocardial Infarction Turk. J. Med. Sci. 2005 35 25 34
227. R. T. Acton J. C. Barton L. V. Passmore P. C. Adams M. R. Speechley F. W. Dawkins P. Sholinsky D. M. Reboussin G. D. McLaren E. L. Harris T. C. Bent T. M. Vogt O. Castro Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study Diabetes Care 2006 29 2084 2089
228. E. M. Alissa W. H. Ahmed N. Al-Ama G. A. Ferns Relationship between indices of iron status and coronary risk factors including diabetes and the metabolic syndrome in Saudi subjects without overt coronary disease J. Trace Elem. Med. Biol. 2007 21 242 254
229. N. G. Forouhi A. H. Harding M. Allison M. S. Sandhu A. Welch R. Luben S. Bingham K. T. Khaw N. J. Wareham Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study Diabetologia 2007 50 949 956
230. M. L. Jehn E. Guallar J. M. Clark D. Couper B. B. Duncan C. M. Ballantyne R. C. Hoogeveen Z. L. Harris J. S. Pankow A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study Am. J. Epidemiol. 2007 165 1047 1054
231. L. Sun O. H. Franco F. B. Hu L. Cai Z. Yu H. Li X. Ye Q. Qi J. Wang A. Pan Y. Liu X. Lin Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese J. Clin. Endocrinol. Metab. 2008 93 4690 4696
232. J. A. Kolberg T. Jørgensen R. W. Gerwien S. Hamren M. P. McKenna E. Moler M. W. Rowe M. S. Urdea X. M. Xu T. Hansen O. Pedersen K. Borch-Johnsen Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort Diabetes Care 2009 32 1207 1212
233. S. N. Rajpathak J. P. Crandall J. Wylie-Rosett G. C. Kabat T. E. Rohan F. B. Hu The role of iron in type 2 diabetes in humans Biochim. Biophys. Acta 2009 1790 671 681
234. C. H. Kim H. K. Kim S. J. Bae J. Y. Park K. U. Lee Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women Metabolism 2011 60 414 420
235. B. K. Lee Y. Kim Y. I. Kim Association of serum ferritin with metabolic syndrome and diabetes mellitus in the South Korean general population according to the Korean National Health and Nutrition Examination Survey 2008 Metabolism 2011 60 1416 1424
236. J. H. Ryoo M. G. Kim D. W. Lee J. Y. Shin The relationship between serum ferritin and metabolic syndrome in healthy Korean men Diabetes/Metab. Res. Rev. 2011 27 597 603
237. W. Bao Y. Rong S. Rong L. Liu Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis BMC Med. 2012 10 119
238. V. Lyssenko T. Jørgensen R. W. Gerwien T. Hansen M. W. Rowe M. P. McKenna J. Kolberg O. Pedersen K. Borch-Johnsen L. Groop Validation of a multi-marker model for the prediction of incident type 2 diabetes mellitus: combined results of the Inter99 and Botnia studies Diabet. Vasc. Dis. Res. 2012 9 59 67
239. J. Montonen H. Boeing A. Steffen R. Lehmann A. Fritsche H. G. Joost M. B. Schulze T. Pischon Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study Diabetologia 2012 55 2613 2621
240. Z. Zhao S. Li G. Liu F. Yan X. Ma Z. Huang H. Tian Body iron stores and heme-iron intake in relation to risk of type 2 diabetes: a systematic review and meta-analysis PLoS One 2012 7 e41641
241. A. O. Aregbesola S. Voutilainen J. K. Virtanen J. Mursu T. P. Tuomainen Body Iron Stores and the Risk of Type 2 Diabetes in Middle-Aged Men Eur. J. Endocrinol. 2013 169 247 253
242. B. Batchuluun T. Matsumata N. Erdenebileg G. Tsagaantsooj K. Boldbaatar A. Khasag Serum ferritin level is higher in poorly controlled patients with Type 2 diabetes and people without diabetes, aged over 55 years Diabetic Med. 2013 10.1111/dme.12343
243. X. Guo D. Zhou P. An Q. Wu H. Wang A. Wu M. Mu D. Zhang Z. Zhang L. He Y. Liu F. Wang Associations between serum hepcidin, ferritin and Hb concentrations and type 2 diabetes risks in a Han Chinese population Br. J. Nutr. 2013 1 6
244. C. H. Jung M. J. Lee J. Y. Hwang J. E. Jang J. Leem J. Y. Park J. Lee H. K. Kim W. J. Lee Elevated serum ferritin level is associated with the incident type 2 diabetes in healthy korean men: a 4 year longitudinal study PLoS One 2013 8 e75250
245. D. Kundu A. Roy T. Mandal U. Bandyopadhyay E. Ghosh D. Ray Relation of iron stores to oxidative stress in type 2 diabetes Niger. J. Clin. Pract. 2013 16 100 103
246. S. K. Kunutsor T. A. Apekey J. Walley K. Kain Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta-analysis of prospective evidence Diabetes/Metab. Res. Rev. 2013 29 308 318
247. L. Sun G. Zong A. Pan X. W. Ye H. X. Li Z. J. Yu Y. Zhao S. R. Zou D. X. Yu Q. L. Jin F. B. Hu X. Lin Elevated Plasma Ferritin Is Associated with Increased Incidence of Type 2 Diabetes in Middle-Aged and Elderly Chinese Adults J. Nutr. 2013 143 1459 1465
248. D. L. White A. Collinson Red meat, dietary heme iron, and risk of type 2 diabetes: the involvement of advanced lipoxidation endproducts Adv. Nutr. 2013 4 403 411
249. N. Wlazlo M. M. J. van Greevenbroek I. Ferreira E. H. J. M. Jansen E. J. M. Feskens C. J. H. van der Kallen C. G. Schalkwijk B. Bravenboer C. D. A. Stehouwer Iron metabolism is associated with adipocyte insulin resistance and plasma adiponectin: the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study Diabetes Care 2013 36 309 315
250. A. Piperno P. Trombini M. Gelosa V. Mauri V. Pecci A. Vergani A. Salvioni R. Mariani G. Mancia Increased serum ferritin is common in men with essential hypertension J. Hypertens. 2002 20 1513 1518
251. E. Coban E. Alkan S. Altuntas Y. Akar Serum ferritin levels correlate with hypertensive retinopathy Med. Sci. Monit. 2010 16 CR92 CR95
252. K. S. Houschyar R. Lüdtke G. J. Dobos U. Kalus M. Broecker-Preuss T. Rampp B. Brinkhaus A. Michalsen Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial BMC Med. 2012 10
253. M. K. Kim K. H. Baek K. H. Song M. I. Kang J. H. Choi J. C. Bae C. Y. Park W. Y. Lee K. W. Oh Increased Serum Ferritin Predicts the Development of Hypertension Among Middle-Aged Men Am. J. Hypertens. 2012 25 492 497
254. B. Choi K. J. Yeum S. J. Park K. N. Kim N. S. Joo Elevated serum ferritin and mercury concentrations are associated with hypertension; analysis of the fourth and fifth Korea national health and nutrition examination survey (KNHANES IV-2, 3, 2008-2009 and V-1, 2010) Environ. Toxicol. 2013 10.1002/tox.21899
255. M. Jehn J. M. Clark E. Guallar Serum ferritin and risk of the metabolic syndrome in U.S. adults Diabetes Care 2004 27 2422 2428
256. C. Bozzini D. Girelli O. Olivieri N. Martinelli A. Bassi G. De Matteis I. Tenuti V. Lotto S. Friso F. Pizzolo R. Corrocher Prevalence of body iron excess in the metabolic syndrome Diabetes Care 2005 28 2061 2063
257. K. M. Choi K. W. Lee H. Y. Kim J. A. Seo S. G. Kim N. H. Kim D. S. Choi S. H. Baik Association among serum ferritin, alanine aminotransferase levels, and metabolic syndrome in Korean postmenopausal women Metabolism 2005 54 1510 1514
258. A. S. González D. B. Guerrero M. B. Soto S. P. Diáz M. Martinez-Olmos O. Vidal Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin Eur. J. Clin. Nutr. 2006 60 802 809
259. V. Tsimihodimos I. Gazi R. Kalaitzidis M. Elisaf K. C. Siamopoulos Increased serum ferritin concentrations and liver enzyme activities in patients with metabolic syndrome Metab. Syndr. Relat. Disord. 2006 4 196 203
260. P. Trombini A. Piperno Ferritin, metabolic syndrome and NAFLD: elective attractions and dangerous liaisons J. Hepatol. 2007 46 549 552
261. I. S. Vari B. Balkau A. Kettaneh P. André J. Tichet F. Fumeron E. Caces M. Marre B. Grandchamp P. Ducimetière Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Diabetes Care 2007 30 1795 1801
262. S. Zelber-Sagi D. Nitzan-Kaluski Z. Halpern R. Oren NAFLD and hyperinsulinemia are major determinants of serum ferritin levels J. Hepatol. 2007 46 700 707
263. S. Tsimikas J. Willeit M. Knoflach M. Mayr G. Egger M. Notdurfter J. L. Witztum C. J. Wiedermann Q. Xu S. Kiechl Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study Eur. Heart J. 2009 30 107 115
264. L. Valenti P. Dongiovanni B. M. Motta D. W. Swinkels P. Bonara R. Rametta L. Burdick C. Frugoni A. L. Fracanzani S. Fargion Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations Arterioscler., Thromb., Vasc. Biol. 2011 31 683 690
265. P. Hämäläinen J. Saltevo H. Kautiainen P. Mäntyselkä M. Vanhala Erythropoietin, ferritin, haptoglobin, hemoglobin and transferrin receptor in metabolic syndrome: a case control study Cardiovasc. Diabetol. 2012 11 116
266. S. K. Park J. H. Ryoo M. G. Kim J. Y. Shin Association of serum ferritin and the development of metabolic syndrome in middle-aged Korean men: a 5-year follow-up study Diabetes Care 2012 35 2521 2526
267. H. T. Kang J. A. Linton J. Y. Shim Serum ferritin level is associated with the prevalence of metabolic syndrome in Korean adults: the 2007-2008 Korean National Health and Nutrition Examination Survey Clin. Chim. Acta 2012 413 636 641
268. J. H. Yoon J. A. Linton S. B. Koh H. T. Kang Serum ferritin concentrations predict incidence of metabolic syndrome in rural Korean adults Clin. Chem. Lab. Med. 2012 50 2057 2059
269. J. S. Chang S. M. Lin T. C. Huang J. C. Chao Y. C. Chen W. H. Pan C. H. Bai Serum ferritin and risk of the metabolic syndrome: a population-based study Asia Pac. J. Clin. Nutr. 2013 22 400 407
270. C. Datz T. K. Felder D. Niederseer E. Aigner Iron homeostasis in the Metabolic Syndrome Eur. J. Clin. Invest. 2013 43 215 224
271. L. Guo F. Jiang Y. T. Tang M. Y. Si X. Y. Jiao The Association of Serum Vascular Endothelial Growth Factor and Ferritin in Diabetic Microvascular Disease Diabetes Technol. Ther. 2013 10.1089/dia.2013.0181
272. J. Li R. Wang D. Luo S. Li C. Xiao Association between Serum Ferritin Levels and Risk of the Metabolic Syndrome in Chinese Adults: A Population Study PLoS One 2013 8 e74168
273. C. Sfagos A. C. Makis A. Chaidos E. C. Hatzimichael A. Dalamaga K. Kosma K. L. Bourantas Serum ferritin, transferrin and soluble transferrin receptor levels in multiple sclerosis patients Mult. Scler. 2005 11 272 275
274. H. Orbach G. Zandman-Goddard H. Amital V. Barak Z. Szekanecz G. Szucs K. Danko E. Nagy T. Csepany J. F. Carvalho A. Doria Y. Shoenfeld Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases Ann. N. Y. Acad. Sci. 2007 1109 385 400
275. G. Zandman-Goddard Y. Shoenfeld Hyperferritinemia in autoimmunity Isr. Med. Assoc. J. 2008 10 83 84
276. R. Da Costa M. Szyper-Kravitz Z. Szekanecz T. Csépány K. Dankó Y. Shapira G. Zandman-Goddard H. Orbach N. Agmon-Levin Y. Shoenfeld Ferritin and Prolactin levels in multiple sclerosis Isr. Med. Assoc. J. 2011 13 91 95
277. J. T. Salonen K. Nyyssonen H. Korpela J. Tuomilehto R. Seppanen R. Salonen High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men Circulation 1992 86 803 811
278. C. Moroz H. Bessler M. Katz I. Zahavi H. Salman M. Djaldetti Elevated serum ferritin level in acute myocardial infarction Biomed. Pharmacother. 1997 51 126 130
279. T. P. Tuomainen K. Punnonen K. Nyyssonen J. T. Salonen Association between body iron stores and the risk of acute myocardial infarction in men Circulation 1998 97 1461 1466
280. K. Klipstein-Grobusch J. F. Koster D. E. Grobbee J. Lindemans H. Boeing A. Hofman J. C. M. Witteman Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam Study Am. J. Clin. Nutr. 1999 69 1231 1236
281. D. Claeys M. Walting F. Julmy W. A. Wuillemin B. J. Meyer Haemochromatosis mutations and ferritin in myocardial infarction: a case-control study Eur. J. Clin. Invest. 2002 32 3 8
282. W. D. Silvia S. Biswas S. Uthappa P. Shetty Ferritin, a potent threat for acute myocardial infarction? J. Assoc. Physicians India 2003 51 947 950
283. X. M. Yuan W. Li The iron hypothesis of atherosclerosis and its clinical impact Ann. Med. 2003 35 578 591
284. M. P. Holay A. A. Choudhary S. D. Suryawanshi Serum ferritin-a novel risk factor in acute myocardial infarction Indian Heart J. 2012 64 173 177
285. M. P. Iqbal N. Mehboobali A. K. Tareen M. Yakub S. P. Iqbal K. Iqbal G. Haider Association of body iron status with the risk of premature acute myocardial infarction in a Pakistani population PLoS One 2013 8 e67981
286. S. Fargion M. Mattioli A. L. Fracanzani M. Sampietro D. Tavazzi P. Fociani E. Taioli L. Valenti G. Fiorelli Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis Am. J. Gastroenterol. 2001 96 2448 2455
287. M. Koruk S. Tayşi M. C. Savaş O. Yilmaz F. Akçay M. Karakök Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis Turk. J. Gastroenterol. 2003 14 12 17
288. E. Bugianesi P. Manzini S. D'Antico E. Vanni F. Longo N. Leone P. Massarenti A. Piga G. Marchesini M. Rizzetto Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver Hepatology 2004 39 179 187
289. T. J. Hsiao J. C. Chen J. D. Wang Insulin resistance and ferritin as major determinants of nonalcoholic fatty liver disease in apparently healthy obese patients Int. J. Obes. Relat. Metab. Disord. 2004 28 167 172
290. C. Loguercio T. De Simone M. V. D'Auria I. de Sio A. Federico C. Tuccillo A. M. Abbatecola C. Del Vecchio Blanco Italian AISF Clinical Group Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver Dig. Liver Dis. 2004 36 398 405
291. G. C. Farrell C. Z. Larter Nonalcoholic fatty liver disease: from steatosis to cirrhosis Hepatology 2006 43 S99 S112
292. L. Valenti A. L. Fracanzani P. Dongiovanni E. Bugianesi G. Marchesini P. Manzini E. Vanni S. Fargion Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study Am. J. Gastroenterol. 2007 102 1251 1258
293. E. Aigner C. Datz Iron perturbations in human non-alcoholic fatty liver disease (NAFLD): Clinical relevance and molecular mechanisms Hepatitis Monthly 2008 8 213 220
294. L. Valenti D. W. Swinkels L. Burdick P. Dongiovanni H. Tjalsma B. M. Motta C. Bertelli E. Fatta D. Bignamini R. Rametta S. Fargion A. L. Fracanzani Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease Nutr., Metab. Cardiovasc. Dis. 2010 21 568 575
295. M. Yoneda Y. Nozaki H. Endo H. Mawatari H. Iida K. Fujita K. Yoneda H. Takahashi H. Kirikoshi M. Inamori N. Kobayashi K. Kubota S. Saito S. Maeyama K. Hotta A. Nakajima Serum ferritin is a clinical biomarker in Japanese patients with nonalcoholic steatohepatitis (NASH) independent of HFE gene mutation Dig. Dis. Sci. 2010 55 808 814
296. K. V. Kowdley The role of iron in nonalcoholic fatty liver disease: the story continues Gastroenterology 2010 138 817 819
297. P. Manousou G. Kalambokis F. Grillo J. Watkins E. Xirouchakis M. Pleguezuelo G. Leandro V. Arvaniti G. Germani D. Patch V. Calvaruso D. P. Mikhailidis A. P. Dhillon A. K. Burroughs Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients Liver Int. 2011 31 730 739
298. Y. Sumida M. Yoneda H. Hyogo K. Yamaguchi M. Ono H. Fujii Y. Eguchi Y. Suzuki S. Imai K. Kanemasa K. Fujita K. Chayama K. Yasui T. Saibara N. Kawada K. Fujimoto Y. Kohgo T. Okanoue A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease J. Gastroenterol. 2011 46 257 268
299. K. V. Kowdley P. Belt L. A. Wilson M. M. Yeh B. A. Neuschwander-Tetri N. Chalasani A. J. Sanyal J. E. Nelson Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease Hepatology 2012 55 77 85
300. C. W. Kim Y. Chang E. Sung H. Shin S. Ryu Serum ferritin levels predict incident non-alcoholic fatty liver disease in healthy Korean men Metabolism 2012 61 1182 1188
301. K. M. Utzschneider A. Largajolli A. Bertoldo S. Marcovina J. E. Nelson M. M. Yeh K. V. Kowdley S. E. Kahn Serum ferritin is associated with non-alcoholic fatty liver disease and decreased Beta-cell function in non-diabetic men and women J. Diabetes Complications 2013 10.1016/j.jdiacomp.2013.11.007
302. S. S. Entman L. D. Richardson A. P. Killam Elevated serum ferritin in the altered ferrokinetics of toxemia of pregnancy Am. J. Obstet. Gynecol. 1982 144 418 422
303. S. S. Entman L. D. Richardson A. P. Killam Altered ferrokinetics in toxemia of pregnancy-a possible indicator of decreased red cell survival Clin. Exp. Hypertens., Part B 1983 2 171 178
304. M. P. Rayman J. Barlis R. W. Evans C. W. Redman L. J. King Abnormal iron parameters in the pregnancy syndrome preeclampsia Am. J. Obstet. Gynecol. 2002 187 412 418
305. C. A. Hubel L. M. Bodnar A. Many G. Harger R. B. Ness J. M. Roberts Nonglycosylated ferritin predominates in the circulation of women with preeclampsia but not intrauterine growth restriction Clin. Chem. 2004 50 948 951
306. I. A. Siddiqui A. Jaleel H. M. Kadri W. A. Saeed W. Tamimi Iron status parameters in preeclamptic women Arch. Gynecol. Obstet. 2011 284 587 591
307. D. R. Blake P. A. Bacon E. J. Eastham K. Brigham Synovial fluid ferritin in rheumatoid arthritis BMJ 1980 281 715 716
308. R. S. Rothwell P. Davis Relationship between serum ferritin, anemia, and disease activity in acute and chronic rheumatoid arthritis Rheumatol. Int. 1981 1 65 67
309. P. Biemond A. J. G. Swaak H. G. Vaneijk J. F. Koster Intraarticular ferritin-bound iron in rheumatoid arthritis-a factor that increases oxygen free radical-induced tissue destruction Arthritis Rheum. 1986 29 1187 1193
310. C. Palermo S. Maddali Bongi G. Bianucci Relationship between serum ferritin, iron stores and disease activity in rheumatoid arthritis Ric. Clin. Lab. 1986 16 463 469
311. P. Biemond A. J. G. Swaak H. G. Vaneijk J. F. Koster Superoxide Dependent Iron Release from Ferritin in Inflammatory Diseases Free Radical Biol. Med. 1988 4 185 198
312. E. Abe M. Arai Synovial fluid ferritin in traumatic hemarthrosis, rheumatoid arthritis and osteoarthritis Tohoku J. Exp. Med. 1992 168 499 505
313. K. Yildirim S. Karatay M. A. Melikoglu G. Gureser M. Ugur K. Senel Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis Ann. Clin. Lab. Sci. 2004 34 423 426
314. F. Lv L. J. Song X. F. Li Combined measurement of multiple acute phase reactants to predict relapse of rheumatoid arthritis Int. J. Rheum. Dis. 2013 10.1111/1756185X.12186
315. R. L. Goldenberg B. M. Mercer M. Miodovnik G. R. Thurnau P. J. Meis A. Moawad R. H. Paul S. F. Bottoms A. Das J. M. Roberts D. McNellis T. Tamura Plasma ferritin, premature rupture of membranes, and pregnancy outcome Am. J. Obstet. Gynecol. 1998 179 1599 1604
316. P. C. R. Garcia F. Longhi R. G. Branco J. P. Piva D. Lacks R. C. Tasker Ferritin levels in children with severe sepsis and septic shock Acta Paediatr. 2007 96 1829 1831
317. T. D. Bennett K. N. Hayward R. W. Farris S. Ringold C. A. Wallace T. V. Brogan Very high serum ferritin levels are associated with increased mortality and critical care in pediatric patients Pediatr. Crit. Care Med. 2011 12 e233 e236
318. M. Suárez-Santamaría F. Santolaria A. Pérez- Ramírez M. R. Aléman-Valls A. Martínez-Riera E. González-Reimers M. J. de la Vega A. Milena Prognostic value of inflammatory markers (notably cytokines and procalcitonin), nutritional assessment, and organ function in patients with sepsis Eur. Cytokine Network 2010 21 19 26
319. A. Dávalos J. M. Fernandezreal W. Ricart S. Soler A. Molins E. Planas D. Genis Iron-related damage in acute ischemic stroke Stroke 1994 25 1543 1546
320. A. K. Erdemoglu S. Ozbakir Serum ferritin levels and early prognosis of stroke Eur. J. Neurol. 2002 9 633 637
321. G. M. Bishop S. R. Robinson Quantitative analysis of cell death and ferritin expression in response to cortical iron: implications for hypoxia-ischemia and stroke Brain Res. 2001 907 175 187
322. A. Armengou A. Davalos A review of the state of research into the role of iron in stroke J. Nutr., Health Aging 2002 6 207 208
323. E. Millerot A. S. Prigent-Tessier N. M. Bertrand P. J. Faure C. M. Mossiat M. E. Giroud A. G. Beley C. Marie Serum ferritin in stroke: a marker of increased body iron stores or stroke severity? J. Cereb. Blood Flow Metab. 2005 25 1386 1393
324. D. L. van der A D. E. Grobbee M. Roest J. J. M. Marx H. A. Voorbij Y. T.
325. M. Millan T. Sobrino M. Castellanos F. Nombela J. F. Arenillas E. Riva I. Cristobo M. M. Garcia J. Vivancos J. Serena M. A. Moro J. Castillo A. Dávalos Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke Stroke 2007 38 90 95
326. M. Mehdiratta S. Kumar D. Hackney G. Schlaug M. Selim Association between serum ferritin level and perihematoma edema volume in patients with spontaneous intracerebral hemorrhage Stroke 2008 39 1165 1170
327. M. Millán T. Sobrino J. F. Arenillas M. Rodriguez- Yáñez M. Garcia F. Nombela M. Castellanos N. Pérez de la Ossa P. Cuadras J. Serena J. Castillo A. Dávalos Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment Dis. Markers 2008 25 181 188
328. N. P. Pérez de la Ossa T. Sobrino Y. Silva M. Blanco M. Millán M. Gomis J. Agulla P. Araya S. Reverté J. Serena A. Dávalos Iron-related brain damage in patients with intracerebral hemorrhage Stroke 2010 41 810 813
329. K. H. Choi M. S. Park J. T. Kim T. S. Nam S. M. Choi B. C. Kim M. K. Kim K. H. Cho The serum ferritin level is an important predictor of hemorrhagic transformation in acute ischaemic stroke Eur. J. Neurol. 2012 19 570 577
330. I. García-Yébenes M. Sobrado A. Moraga J. G. Zarruk V. G. Romera J. M. Pradillo N. Perez de la Ossa M. A. Moro A. Dávalos I. Lizasoain Iron overload, measured as serum ferritin, increases brain damage induced by focal ischemia and early reperfusion Neurochem. Int. 2012 61 1364 1369
331. K. Nishiya K. Hashimoto Elevation of serum ferritin levels as a marker for active systemic lupus erythematosus Clin. Exp. Rheumatol. 1997 15 39 44
332. M. K. Lim C. K. Lee Y. S. Ju Y. S. Cho M. S. Lee B. Yoo H. B. Moon Serum ferritin as a serologic marker of activity in systemic lupus erythematosus Rheumatol. Int. 2001 20 89 93
333. L. G. Xu M. Wu J. C. Hu Z. H. Zhai H. B. Shu Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1 J. Leukocyte Biol. 2002 72 410 416
334. E. Beyan C. Beyan A. Demirezer E. Ertugrul A. Uzuner The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus Scand. J. Rheumatol. 2003 32 225 228
335. G. Zandman-Goddard H. Orbach H. Amital Z. Szekanecz G. Szucs K. Danko E. Nagy T. Csepany Y. Shoenfeld Elevated levels of ferritin in systemic lupus erythematosus and other autoimmune diseases Ann. Rheum. Dis. 2007 66 488
336. A. Parodi S. Davi A. B. Pringe A. Pistorio N. Ruperto S. Magni-Manzoni P. Miettunen B. Bader-Meunier G. Espada G. Sterba S. Ozen D. Wright C. S. Magalhaes R. Khubchandani H. Michels P. Woo A. Iglesias D. Guseinova C. Bracaglia K. Hayward C. Wouters A. Grom M. Vivarelli A. Fischer L. Breda A. Martini A. Ravelli P. R. E. Soc Macrophage Activation Syndrome in Juvenile Systemic Lupus Erythematosus A Multinational Multicenter Study of Thirty-Eight Patients Arthritis Rheum. 2009 60 3388 3399
337. K. Vanarsa Y. Ye J. Han C. Xie C. Mohan T. Wu Inflammation associated anemia and ferritin as disease markers in SLE Arthritis Res. Ther. 2012 14 R182
338. M. Abbasi M. Sahebari A. Amini M. Saghafi Hyperferritinemia: A possible marker for diagnosis of systemic lupus erythematosus? Life Sci. J. 2013 10 335 337
339. S. Y. Lee S. W. Lee W. T. Chung Severe inflammation may be caused by hyperferritinemia of pseudo-pseudo Meigs' syndrome in lupus patients: two cases reports and a literature review Clin. Rheumatol. 2013 32 1823 1826
340. M. A. B. Lozovoy A. N. C. Simão S. R. Oliveira T. M. V. Iryioda C. Panis R. Cecchini I. Dichi Relationship between iron metabolism, oxidative stress, and insulin resistance in patients with systemic lupus erythematosus Scand. J. Rheumatol. 2013 42 303 310
341. S. Vilaiyuk N. Sirachainan S. Wanitkun K. Pirojsakul J. Vaewpanich Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: a case-based review Clin. Rheumatol. 2013 32 899 904
342. G. Zandman-Goddard H. Orbach N. Agmon-Levin M. Boaz H. Amital Z. Szekanecz G. Szucs J. Rovensky E. Kiss N. Corocher A. Doria L. Stojanovich F. Ingegnoli P. L. Meroni B. Rozman J. Gomez-Arbesu M. Blank Y. Shoenfeld Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients Clin. Rev. Allergy Immunol. 2013 44 23 30
343. A. Undas P. Podolec K. Zawilska M. Pieculewicz I. Jedliński E. Stȩpień E. Konarska-Kuszewska P. Weglarz M. Duszynska E. Hanschke T. Przewlocki W. Tracz Altered fibrin clot structure/function in patients with cryptogenic ischemic stroke Stroke 2009 40 1499 1501
344. I. Palka J. Nessler B. Nessler W. Piwowarska W. Tracz A. Undas Altered fibrin clot properties in patients with chronic heart failure and sinus rhythm: a novel prothrombotic mechanism Heart 2010 96 1114 1118
345. A. Undas R. A. S. Ariëns Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases Arterioscler., Thromb., Vasc. Biol. 2011 31 e88 e99
346. A. Undas M. Cieśla-Dulb T. Drzkiewiczb J. Sadowski Altered fibrin clot properties are associated with residual vein obstruction: effects of lipoprotein(a) and apolipoprotein(a) isoform Thromb. Res. 2012 130 e184 e187
347. J. Bester A. V. Buys B. Lipinski D. B. Kell E. Pretorius High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease Front. Aging Neurosci. 2013 5 00088
348. E. Pretorius B. Lipinski Thromboembolic ischemic stroke changes red blood cell morphology Cardiovasc. Pathol. 2013 22 241 242
349. E. Pretorius B. Lipinski Iron alters red blood cell morphology Blood 2013 121 9
350. E. Pretorius J. Bester N. Vermeulen B. Lipinski G. S. Gericke D. B. Kell Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents PLoS One 2014 9 e85271
351. E. Pretorius N. Vermeulen J. Bester Atypical erythrocytes and platelets in a patient with a pro-thrombin mutation Platelets 2013 10.3109/09537104.2013. 830709
352. E. Pretorius N. Vermeulen J. Bester B. Lipinski D. B. Kell A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopy Toxicol. Mech. Methods 2013 23 352 359
353. B. Lipinski E. Pretorius H. M. Oberholzer W. J. van der Spuy Interaction of fibrin with red blood cells: the role of iron Ultrastruct. Pathol. 2012 36 79 84
354. B. Lipinski E. Pretorius Novel pathway of iron-induced blood coagulation: implications for diabetes mellitus and its complications Pol. Arch. Med. Wewn. 2012 122 115 122
355. E. Pretorius J. du Plooy P. Soma A. Y. Gasparyan An ultrastructural analysis of platelets, erythrocytes, white blood cells, and fibrin network in systemic lupus erythematosus Rheumatol. Int. 2013 10.1007/s00296-013-2817-x
356. A. V. Buys M. J. Van Rooy P. Soma D. Van Papendorp B. Lipinski E. Pretorius Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study Cardiovasc. Diabetol. 2013 12 25
357. S. Gangopadhyay V. K. Vijayan S. K. Bansal Lipids of erythrocyte membranes of COPD patients: a quantitative and qualitative study COPD 2012 9 322 331
358. E. Pretorius J. N. du Plooy P. Soma I. Keyser A. V. Buys Smoking and fluidity of erythrocyte membranes: A high resolution scanning electron and atomic force microscopy investigation Nitric Oxide 2013 35C 42 46
359. C. J. Smith T. H. Fischer Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction Atherosclerosis 2001 158 257 267
360. G. J. Kontoghiorghes Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. Comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers Hemoglobin 2006 30 329 347
361. H. Nick Iron chelation, quo vadis? Curr. Opin. Chem. Biol. 2007 11 419 423
362. A. Maggio A. Filosa A. Vitrano G. Aloj A. Kattamis A. Ceci S. Fucharoen P. Cianciulli R. W. Grady L. Prossomariti J. B. Porter A. Iacono M. D. Cappellini F. Bonifazi F. Cassara P. Harmatz J. Wood C. Gluud Iron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trials Blood Cells, Mol., Dis. 2011 47 166 175
363. E. A. Rachmilewitz P. J. Giardina How I treat thalassemia Blood 2011 118 3479 3488
364. Y. Ma T. Zhou X. Kong R. C. Hider Chelating agents for the treatment of systemic iron overload Curr. Med. Chem. 2012 19 2816 2827
365. T. P. Chang C. Rangan Iron poisoning: a literature-based review of epidemiology, diagnosis, and management Pediatr. Emerg. Care 2011 27 978 985
366. A. J. Matthews G. M. Vercellotti H. J. Menchaca P. H. Bloch V. N. Michalek P. H. Marker J. Murar H. Buchwald Iron and atherosclerosis: inhibition by the iron chelator deferiprone (L1) J. Surg. Res. 1997 73 35 40
367. K. M. Mitchell A. L. Dotson K. M. Cool A. Chakrabarty S. H. Benedict S. M. LeVine Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis Mult. Scler. 2007 13 1118 1126
368. R. Galanello Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective Ther. Clin. Risk Manage. 2007 3 795 805
369. W. T. Lindsey B. R. Olin Deferasirox for transfusion-related iron overload: a clinical review Clin. Ther. 2007 29 2154 2166
370. M. D. Cappellini A. Taher Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overload Expert Opin. Pharmacother. 2008 9 2391 2402
371. C. McLeod N. Fleeman J. Kirkham A. Bagust A. Boland P. Chu R. Dickson Y. Dundar J. Greenhalgh B. Modell A. Olujohungbe P. Telfer T. Walley Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation Health Technol. Assess. 2009 13
372. M. D. Cappellini J. Porter A. El-Beshlawy C. K. Li J. F. Seymour M. Elalfy N. Gattermann S. Giraudier J. W. Lee L. L. Chan K. H. Lin C. Rose A. Taher S. L. Thein V. Viprakasit D. Habr G. Domokos B. Roubert A. Kattamis Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias Haematologica 2010 95 557 566
373. J. A. Joseph N. A. Denisova D. Bielinski D. R. Fisher B. Shukitt-Hale Oxidative stress protection and vulnerability in aging: putative nutritional implications for intervention Mech. Ageing Dev. 2000 116 141 153
374. K. E. Heim A. R. Tagliaferro D. J. Bobilya Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships J. Nutr. Biochem. 2002 13 572 584
375. S. R. McAnulty L. S. McAnulty D. C. Nieman C. L. Dumke J. D. Morrow A. C. Utter D. A. Henson W. R. Proulx G. L. George Consumption of blueberry polyphenols reduces exercise-induced oxidative stress compared to vitamin C Nutr. Res. 2004 24 209 221
376. P. Velayutham A. Babu D. M. Liu Green tea catechins and cardiovascular health: an update Curr. Med. Chem. 2008 15 1840 1850
377. M. Akhlaghi B. Bandy Mechanisms of flavonoid protection against myocardial ischemia-reperfusion injury J. Mol. Cell. Cardiol. 2009 46 309 317
378. N. R. Perron J. L. Brumaghim A review of the antioxidant mechanisms of polyphenol compounds related to iron binding Cell Biochem. Biophys. 2009 53 75 100
379. N. R. Perron H. C. Wang S. N. Deguire M. Jenkins M. Lawson J. L. Brumaghim Kinetics of iron oxidation upon polyphenol binding Dalton Trans. 2010 39 9982 9987
380. N. R. Perron C. R. Garcia J. R. Pinzon M. N. Chaur J. L. Brumaghim Antioxidant and prooxidant effects of polyphenol compounds on copper-mediated DNA damage J. Inorg. Biochem. 2011 105 745 753
381. R. A. Jacob H. H. Sandstead L. M. Klevay L. K. Johnson Utility of serum ferritin as a measure of iron deficiency in normal males undergoing repetitive phlebotomy Blood 1980 56 786 791
382. C. A. Finch V. Bellotti S. Stray D. A. Lipschitz J. D. Cook M. J. Pippard H. A. Huebers Plasma ferritin determination as a diagnostic tool West. J. Med. 1986 145 657 663
383. J. D. Cook C. H. Flowers B. S. Skikne The quantitative assessment of body iron Blood 2003 101 3359 3364
384. A. Kolnagou D. Yazman C. Economides E. Eracleous G. J. Kontoghiorghes Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol Hemoglobin 2009 33 312 322
385. B. D. Maliken W. F. Avrin J. E. Nelson J. Mooney S. Kumar K. V. Kowdley Room-temperature susceptometry predicts biopsy-determined hepatic iron in patients with elevated serum ferritin Ann. Hepatol. 2012 11 77 84
386. M. Worwood S. J. Cragg M. Wagstaff A. Jacobs Binding of human serum ferritin to concanavalin A Clin. Sci. 1979 56 83 87
387. N. C. Andrews Forging a field: the golden age of iron biology Blood 2008 112 219 230
388. A. E. Hamburger A. P. West Z. A. Hamburger P. Hamburger P. J. Bjorkman Crystal structure of a secreted insect ferritin reveals a symmetrical arrangement of heavy and light chains J. Mol. Biol. 2005 349 558 569
389. S. Ghosh S. Hevi S. L. Chuck Regulated secretion of glycosylated human ferritin from hepatocytes Blood 2004 103 2369 2376
390. T. N. Tran S. K. Eubanks K. J. Schaffer C. Y. J. Zhou M. C. Linder Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron Blood 1997 90 4979 4986
391. J. Y. Li N. Paragas R. M. Ned A. Qiu M. Viltard T. Leete I. R. Drexler X. Chen S. Sanna-Cherchi F. Mohammed D. Williams C. S. Lin K. M. Schmidt-Ott N. C. Andrews J. Barasch Scara5 is a ferritin receptor mediating non-transferrin iron delivery Dev. Cell 2009 16 35 46
392. L. Li C. J. Fang J. C. Ryan E. C. Niemi J. A. Lebrón P. J. Björkman H. Arase F. M. Torti S. V. Torti M. C. Nakamura W. E. Seaman Binding and uptake of H-ferritin are mediated by human transferrin receptor-1 Proc. Natl. Acad. Sci. U. S. A. 2010 107 3505 3510
393. J. Han W. E. Seaman X. M. Di W. Wang M. Willingham F. M. Torti S. V. Torti Iron Uptake Mediated by Binding of H-Ferritin to the TIM-2 Receptor in Mouse Cells PLoS One 2011 6
394. J. C. Sibille H. Kondo P. Aisen Interactions between Isolated Hepatocytes and Kupffer Cells in Iron Metabolism-a Possible Role for Ferritin as an Iron Carrier Protein Hepatology 1988 8 296 301
395. L. A. Cohen L. Gutierrez A. Weiss Y. Leichtmann-Bardoogo D. L. Zhang D. R. Crooks R. Sougrat A. Morgenstern B. Galy M. W. Hentze F. J. Lazaro T. A. Rouault E. G. Meyron-Holtz Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway Blood 2010 116 1574 1584
396. R. Wilkinson and K. Pickett, The spirit level: why equality is better for everyone, Penguin Books, London, 2009
397. R. W. G. Chapman A. Gorman M. Laulicht M. A. Hussain S. Sherlock A. V. Hoffbrand Binding of Serum Ferritin to Concanavalin-a in Patients with Iron Overload and with Chronic Liver-Disease J. Clin. Pathol. 1982 35 481 486
398. T. V. Adamkiewicz M. R. Abboud C. Paley N. Olivieri M. Kirby-Allen E. Vichinsky J. F. Casella O. A. Alvarez J. C. Barredo M. T. Lee R. V. Iyer A. Kutlar K. M. McKie V. McKie N. Odo B. Gee J. L. Kwiatkowski G. M. Woods T. Coates W. Wang R. J. Adams Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury Blood 2009 114 4632 4638
399. T. Takikawa H. Hayashi N. Nishimura M. Yano T. Isomura N. Sakamoto Correlation between serum levels of alanine aminotransferase and ferritin in male blood donors with antibody to hepatitis C virus J. Gastroenterol. 1994 29 593 597
400. C. Caramelo M. Albalate T. Bermejillo S. Navas A. Ortiz P. de Sequera S. Casado V. Carreño Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients with hepatitis C virus Nephrol., Dial., Transplant. 1996 11 1792 1796
401. B. Dubern J. P. Girardet P. Tounian Insulin resistance and ferritin as major determinants of abnormal serum aminotransferase in severely obese children Int. J. Pediatr. Obes. 2006 1 77 82
402. T. Nakagawa Y. Muramoto M. Hori S. Mihara T. Marubayashi K. Nakagawa A preliminary investigation of the association between haptoglobin polymorphism, serum ferritin concentration and fatty liver disease Clin. Chim. Acta 2008 398 34 38
403. M. Iwasa N. Hara K. Iwata M. Ishidome R. Sugimoto H. Tanaka N. Fujita Y. Kobayashi Y. Takei Restriction of calorie and iron intake results in reduction of visceral fat and serum alanine aminotransferase and ferritin levels in patients with chronic liver disease Hepatol. Res. 2010 40 1188 1194
404. E. Ozawa S. Abiru S. Nagaoka K. Yano A. Komori K. Migita H. Yatsuhashi N. Taura T. Ichikawa H. Ishibashi K. Nakao Ferritin/alanine aminotransferase ratio as a possible marker for predicting the prognosis of acute liver injury J. Gastroenterol. Hepatol. 2011 26 1326 1332
405. P. C. Adams J. C. Barton A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation J. Hepatol. 2011 55 453 458
406. S. Uysal F. Armutcu T. Aydogan K. Akin M. Ikizek M. R. Yigitoglu Some inflammatory cytokine levels, iron metabolism and oxidan stress markers in subjects with nonalcoholic steatohepatitis Clin. Biochem. 2011 44 1375 1379
407. A. Oguz A. E. Atay A. Tas G. Seven M. Koruk Predictive role of acute phase reactants in the response to therapy in patients with chronic hepatitis C virus infection Gut Liver 2013 7 82 88
408. J. C. Waterlow, P. J. Garlick and D. J. Millward, Protein Turnover in Mammalian Tissues and in the Whole Body, Elsevier/North-Holland, Amsterdam, 1978
409. H. A. Johnson R. L. Baldwin J. France C. C. Calvert A model of whole-body protein turnover based on leucine kinetics in rodents J. Nutr. 1999 129 728 739
410. J. Pellettieri A. Sanchez Alvarado Cell turnover and adult tissue homeostasis: from humans to planarians Annu. Rev. Genet. 2007 41 83 105
411. A. J. Claydon R. J. Beynon Proteome dynamics: revisiting turnover with a global perspective Mol. Cell. Proteomics 2012 11 1551 1565
412. G. Balla H. S. Jacob J. Balla M. Rosenberg K. Nath F. Apple J. W. Eaton G. M. Vercellotti Ferritin: a cytoprotective antioxidant strategem of endothelium J. Biol. Chem. 1992 267 18148 18153
413. K. Orino L. Lehman Y. Tsuji H. Ayaki S. V. Torti F. M. Torti Ferritin and the response to oxidative stress Biochem. J. 2001 357 241 247
414. Y. Tsuji H. Ayaki S. P. Whitman C. S. Morrow S. V. Torti F. M. Torti Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress Mol. Cell. Biol. 2000 20 5818 5827
415. K. Hailemariam K. Iwasaki B. W. Huang K. Sakamoto Y. Tsuji Transcriptional regulation of ferritin and antioxidant genes by HIPK2 under genotoxic stress J. Cell Sci. 2010 123 3863 3871
416. B. W. Huang P. D. Ray K. Iwasaki Y. Tsuji Transcriptional regulation of the human ferritin gene by coordinated regulation of Nrf2 and protein arginine methyltransferases PRMT1 and PRMT4 FASEB J. 2013 27 3763 3774
417. M. Nakano Y. Kawanishi S. Kamohara Y. Uchida M. Shiota Y. Inatomi T. Komori K. Miyazawa K. Gondo I. Yamasawa Oxidative DNA damage (8-hydroxydeoxyguanosine) and body iron status: a study on 2507 healthy people Free Radical Biol. Med. 2003 35 826 832
418. Y. Maruyama M. Nakayama K. Yoshimura H. Nakano H. Yamamoto K. Yokoyama B. Lindholm Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2′-deoxyguanosine levels Nephrol., Dial., Transplant. 2007 22 1407 1412
419. T. P. Tuomainen S. Loft K. Nyyssonen K. Punnonen J. T. Salonen H. E. Poulsen Body iron is a contributor to oxidative damage of DNA Free Radical Res. 2007 41 324 328
420. N. Fujita R. Sugimoto N. Ma H. Tanaka M. Iwasa Y. Kobayashi S. Kawanishi S. Watanabe M. Kaito Y. Takei Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C J. Viral Hepat. 2008 15 498 507
421. K. L. Kuo S. C. Hung Y. H. Wei D. C. Tarng Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients J. Am. Soc. Nephrol. 2008 19 1817 1826
422. K. Broedbaek H. E. Poulsen A. Weimann G. D. Kom E. Schwedhelm P. Nielsen R. H. Boger Urinary excretion of biomarkers of oxidatively damaged DNA and RNA in hereditary hemochromatosis Free Radical Biol. Med. 2009 47 1230 1233
423. A. Hori T. Mizoue H. Kasai K. Kawai Y. Matsushita A. Nanri M. Sato M. Ohta Body iron store as a predictor of oxidative DNA damage in healthy men and women Cancer Sci. 2010 101 517 522
424. K. Broedbaek V. Siersma J. T. Andersen M. Petersen S. Afzal B. Hjelvang A. Weimann R. D. Semba L. Ferrucci H. E. Poulsen The association between low-grade inflammation, iron status and nucleic acid oxidation in the elderly Free Radical Res. 2011 45 409 416
425. T. P. Tuomainen U. Diczfalusy J. Kaikkonen K. Nyyssonen J. T. Salonen Serum ferritin concentration is associated with plasma levels of cholesterol oxidation products in man Free Radical Biol. Med. 2003 35 922 928
426. S. Yeoh-Ellerton M. C. Stacey Iron and 8-isoprostane levels in acute and chronic wounds J. Invest. Dermatol. 2003 121 918 925
427. C. Matayatsuk C. Y. Lee R. W. Kalpravidh P. Sirankapracha P. Wilairat S. Fucharoen B. Halliwell Elevated F2-isoprostanes in thalassemic patients Free Radical Biol. Med. 2007 43 1649 1655
428. A. P. Jewell R. E. Marcus Platelet Derived Malonyldialdehyde Production in Patients with Thalassemia Major J. Clin. Pathol. 1984 37 1043 1045
429. F. Farinati R. Cardin N. Demaria G. Dellalibera C. Marafin E. Lecis P. Burra A. Floreani A. Cecchetto R. Naccarato Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis J. Hepatol. 1995 22 449 456
430. J. Mimić-Oka A. Savić-Radojević M. PljeŠa-Ercegovac M. Opačić T. Simić N. Dimković D. V. Simić Evaluation of oxidative stress after repeated intravenous iron supplementation Renal Failure 2005 27 345 351
431. A. S. De Vriese D. Borrey E. Mahieu I. Claeys L. Stevens A. Vanhaeverbeke M. Roelens M. R. Langlois Oral vitamin C administration increases lipid peroxidation in hemodialysis patients Nephron Clin. Pract. 2008 108 c28 c34
432. S. M. King C. M. Donangelo M. D. Knutson P. B. Walter B. N. Ames F. E. Viteri J. C. King Daily supplementation with iron increases lipid peroxidation in young women with low iron stores Exp. Biol. Med. 2008 233 701 707
433. J. F. R. Mendes S. F. Arruda E. M. de Almeida Siqueira M. K. Ito E. F. da Silva Iron status and oxidative stress biomarkers in adults: a preliminary study Nutrition 2009 25 379 384
434. A. I. Alsultan M. A. Seif T. T. Amin M. Naboli A. M. Alsuliman Relationship between oxidative stress, ferritin and insulin resistance in sickle cell disease Eur. Rev. Med. Pharmacol. Sci. 2010 14 527 538
435. T. E. de Jesus dos Santos G. F. de Sousa M. C. Barbosa R. P. Goncalves The role of iron overload on oxidative stress in sickle cell anemia Biomarkers Med. 2012 6 813 819
436. M. S. Elalfy A. A. Adly A. A. Attia F. A. Ibrahim A. S. Mohammed A. M. Sayed Effect of antioxidant therapy on hepatic fibrosis and liver iron concentrations in beta-thalassemia major patients Hemoglobin 2013 37 257 276
437. E. A. Decker B. Welch Role of ferritin as a lipid oxidation catalyst in muscle food J. Agric. Food Chem. 1990 38 674 677
438. J. I. Gray E. A. Gomaa D. J. Buckley Oxidative quality and shelf life of meats Meat Sci. 1996 43 S111 S123
439. D. U. Ahn S. M. Kim Prooxidant effects of ferrous iron, hemoglobin, and ferritin in oil emulsion and cooked-meat homogenates are different from those in raw-meat homogenates Poult. Sci. 1998 77 348 355
440. D. U. Ahn F. H. Wolfe J. S. Sim The Effect of Metal Chelators, Hydroxyl Radical Scavengers, and Enzyme-Systems on the Lipid-Peroxidation of Raw Turkey Meat Poult. Sci. 1993 72 1972 1980
441. T. Wang R. Jónsdóttir G. Ólafsdóttir Total phenolic compounds, radical scavenging and metal chelation of extracts from Icelandic seaweeds Food Chem. 2009 116 240 248
442. F. Lang E. Lang M. Foller Physiology and pathophysiology of eryptosis Transfus. Med. Hemother. 2012 39 308 314
443. M. M. Aleman C. Gardiner P. Harrison A. S. Wolberg Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability J. Thromb. Haemostasis 2011 9 2251 2261
444. C. T. Nielsen O. Østergaard C. Johnsen S. Jacobsen N. H. H. Heegaard Distinct features of circulating microparticles and their relationship to clinical manifestations in Systemic Lupus Erythematosus Arthritis Rheum. 2011 63 3067 3077
445. C. T. Nielsen Circulating microparticles in systemic Lupus Erythematosus Dan. Med. J. 2012 59 B4548
446. C. T. Nielsen O. Østergaard L. Stener L. V. Iversen L. Truedsson B. Gullstrand S. Jacobsen N. H. H. Heegaard Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation Arthritis Rheum. 2012 64 1227 1236
447. L. V. Iversen O. Østergaard C. T. Nielsen S. Jacobsen N. H. H. Heegaard A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer J. Immunol. Methods 2013 388 49 59
448. L. Iversen O. Østergaard S. Ullman C. T. Nielsen P. Halberg T. Karlsmark N. H. H. Heegaard S. Jacobsen Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis Scand. J. Rheumatol. 2013 42 473 482
449. O. Østergaard C. T. Nielsen L. V. Iversen J. T. Tanassi S. Knudsen S. Jacobsen N. H. H. Heegaard Unique protein signature of circulating microparticles in systemic lupus erythematosus Arthritis Rheum. 2013 65 2680 2690
450. B. Parker A. Al-Husain P. Pemberton A. P. Yates P. Ho R. Gorodkin L. S. Teh M. Y. Alexander I. N. Bruce Suppression of inflammation reduces endothelial microparticles in active systemic lupus erythematosus Ann. Rheum. Dis. 2013 10.1136/annrheumdis-2012-203028
451. J. Pereira G. Alfaro M. Goycoolea T. Quiroga M. Ocqueteau L. Massardo C. Pérez C. Sáez O. Panes V. Matus D. Mezzano Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state Thromb. Haemostasis 2006 95 94 99
452. A. A. G. Tantawy A. A. M. Adly E. A. R. Ismail N. M. Habeeb Flow cytometric assessment of circulating platelet and erythrocytes microparticles in young thalassemia major patients: relation to pulmonary hypertension and aortic wall stiffness Eur. J. Haematol. 2013 90 508 518
453. A. A. G. Tantawy A. A. M. Adly E. A. R. Ismail N. M. Habeeb A. Farouk Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications Platelets 2013 24 605 614
454. I. Porto G. L. De Maria L. Di Vito C. Camaioni M. Gustapane L. M. Biasucci Microparticles in health and disease: small mediators, large role? Curr. Vasc. Pharmacol. 2011 9 490 500
455. P. E. Spronk H. Bootsma C. G. M. Kallenberg Anti-DNA antibodies as early predictor for disease exacerbations in SLE-Guideline for treatment? Clin. Rev. Allergy Immunol. 1998 16 211 218
456. N. Agmon-Levin C. Rosário B. S. Katz G. Zandman-Goddard P. Meroni R. Cervera L. Stojanovich M. Blank S. Pierangeli S. Praprotnik E. Meis L. P. Seguro A. Ruffatti V. Pengo A. Tincani A. Doria Y. Shoenfeld Ferritin in the antiphospholipid syndrome and its catastrophic variant (cAPS) Lupus 2013 22 1327 1335
457. C. Rosário G. Zandman-Goddard E. G. Meyron-Holtz D. P. D'Cruz Y. Shoenfeld The Hyperferritinemic Syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome BMC Med. 2013 11 185
458. D. B. Kell R. Goodacre Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery Drug Discovery Today 2014 19 171 182